Takeda PharmaceuticalsThis is a Strategy Evaluation and Guidance Report.Key aspects of this report are evaluating the company past performance (be as negative as possible) and explain why they have failed while their competitors have succeeded.Then follow the template by giving potential solutions and how to improve their strategy and performance.
Executive SummaryStrategic AnalysisExternal strategic analysisInternal strategic analysis
Strategy development next three yearsStrategy implementation for the next three years
AppendicesPROPOSALTakeda PharmaceuticalsThis is a Strategy Evaluation and Guidance Report.Key aspects of this report are evaluating the company past performance (be as negative as possible) and explain why they have failed while their competitors have succeeded.Then follow the template by giving potential solutions and how to improve their strategy and performance.
Takeda PharmaceuticalsTakeda Pharmaceuticals Company Limited is a Japanese multinational pharmaceutical company that operates worldwide. The business unit being reviewed is Takeda Pharmaceuticals U.S.A, Inc. This unit is Takedas largest outside of Japan contributing to 30 percent of the companys global revenue. The company primarily focuses on oncology, gastroenterology, neuroscience, rare diseases and vaccine development. Takedas market share has been gradually decreasing over the past 5 years, losing to direct competitors such as Roche, Novartis and Pfizer.Figure 1 Revenue data gathered from each companies annual reports (2020)Figure 2Strategic Competitive ChallengesTakeda possesses internal and external challenges which negatively impact the organisation. These challenges directly contribute to the consistent decline in market share alongside share price as investors are dissuaded by the potential risks of investment.Some of the issues Takeda faces include:Internal mismanagementLack of innovationWrong investment decisionsFailure to acquire appropriate talentPoor marketing decisionThese problems are left unchecked resulting in failure to formulate an appropriate response strategy.In the HR department there is clear evidence of mismanagement. Its competitors can simply attract more talent given its strong presence in universities and associate programmes. Meanwhile Takeda offers little incentives for medical graduates seeking vital positions within the industry.Industry research also suggests Takedas employees on average are paid 10-20 percent less than their direct competitors for the same position. This decreases the possibility of recruitment and retention.Figure 3Comparing experimental drug breakthroughs provides a clear insight into the companys research and development practices. The industry has developed significantly more drugs compared to Takeda despite it having 2.7 percent of market share in the same period.Figure 4Some of the marketing decisions Takeda has made has also been questionable, using ineffective methods, often neglecting the key aspects of modern marketing strategies. An example of this is the lack of a social media presence.Its acquisition history in the past decade has also contributed to the poor liquidity. Its recent purchase of Shire Ltd. has placed Takeda into a further 5.75 trillion yen of debt, resulting in further reduction of share price.Once all these challenges are taken into consideration, it is not surprising to see the current downward trajectory Takeda has experienced. All these failures contributed to a breakdown of trust amongst investors which resulted in a reduction of stock price alongside with stagnated revenues.Research planThe research plan consists of an overview into the industry trends which will be used to benchmark Takedas performance against its competitors. This provides technical insight into challenges that are commonly shared which allows the strategy to be extrapolated.Analytical ToolsSWOTSTEEPInformation SourcesMonthly Index of Medical Specialties (MIMS)MIMs is a drug reference utilised by medical professionals on pharmaceutical compounds. This tool is vital in understanding changes in the industry along with the key competitors involved in the market.Industry TimelineA timeline of major events occurring in the industry – which can be found on Fame, Orbis, Lexis and Mintel.Pharmaceutical Industry NewsIndustry ReportsIndustry reports contrasted with Takedas annual reports will provide insight into the internal struggles.Annual ReportsFinancial ReportsPerformance AnalysisKey AcquisitionsNew Drug DevelopmentTalent ManagementBalance SheetIncome statementReport Development Chart
classassignmenthelp.com Plagiarism Free Papers
Are you looking for custom essay writing service or even dissertation writing services? Just request for our write my paper service, and we\’ll match you with the best essay writer in your subject! With an exceptional team of professional academic experts in a wide range of subjects, we can guarantee you an unrivaled quality of custom-written papers.
Why Hire classassignmenthelp.com writers to do your paper?
Quality- We are experienced and have access to ample research materials.
We write plagiarism Free Content
Confidential- We never share or sell your personal information to third parties.
Support-Chat with us today! We are always waiting to answer all your questions.